Amanda Lynn Ward, NP-C in Albion, ID - Nurse Practitioner

Amanda Lynn Ward, NP-C is a Nurse Practitioner - Family based in Albion, Idaho. Amanda Lynn Ward is licensed to practice in Idaho (license number NP-1514A) and her current practice location is 950s 1325e, Albion, Idaho. She can be reached at her office (for appointments etc.) via phone at (208) 312-9740.

NPI number for Amanda Lynn Ward is 1952707184 and her current mailing address is Po Box 43, Albion, Idaho. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1952707184.

Contact Information

	Amanda Lynn Ward, NP-C
	950s 1325e, Albion, ID 83311
	(208) 312-9740
	(208) 678-0910

Provider's Profile

Full Name	Amanda Lynn Ward
Gender	Female
Speciality	Nurse Practitioner - Family
Location	950s 1325e, Albion, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1952707184
Provider Enumeration Date: 11/17/2014
Last Update Date: 11/17/2014

Medical Identifiers

Medical identifiers for Amanda Lynn Ward such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952707184	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LF0000X	Nurse Practitioner - Family	NP-1514A (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amanda Lynn Ward is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Amanda Lynn Ward, NP-C Po Box 43, Albion, ID 83311-0043 Ph: (208) 312-9740	Amanda Lynn Ward, NP-C 950s 1325e, Albion, ID 83311 Ph: (208) 312-9740

News Archive

New analysis highlights prevalence of cognitive impairment and changes in breast cancer patients

A recent analysis of published studies estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy.

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.

Molecular study reveals signs of inflammation in brains of people who died of COVID-19

The most comprehensive molecular study to date of the brains of people who died of COVID-19 turned up unmistakable signs of inflammation and impaired brain circuits.

Researchers identify six genes with driving mutations in melanoma

It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer? None have been conclusively tied to melanoma. The sheer abundance of these passenger mutations has obscured the search for genetic driver mutations that actually matter in melanoma development and progression.

Self-collected saliva and deep nasal swabs are equally effective for detecting SARS-CoV-2

Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study conducted by ARUP Laboratories and University of Utah Health.

Amanda Lynn Ward, NP-C - Nurse Practitioner in Albion, ID